These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37819717)

  • 1. Utilization of Hydrogels in Mesenchymal Stem Cell-Based Therapy for Kidney Diseases.
    Peng J; Yang T; Chen S; Deng N; Luo X; Liao R; Su B
    Tissue Eng Part B Rev; 2024 Jun; 30(3):315-326. PubMed ID: 37819717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin preconditioning is an effective strategy for mesenchymal stem cell-based therapy for kidney disease.
    Zhao L; Hu C; Zhang P; Jiang H; Chen J
    J Cell Mol Med; 2020 Jan; 24(1):25-33. PubMed ID: 31747719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Kidney Capsule Packed with Mesenchymal Stem Cell-Laden Hydrogel for the Treatment of Rhabdomyolysis-Induced Acute Kidney Injury.
    Fu Z; Chu Y; Geng X; Ma Y; Chi K; Song C; Liao S; Hong Q; Wu D; Wang Y
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1726-1734. PubMed ID: 35302761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.
    Wang H; Shang Y; Chen X; Wang Z; Zhu D; Liu Y; Zhang C; Chen P; Wu J; Wu L; Kong D; Yang Z; Li Z; Chen X
    Int J Nanomedicine; 2020; 15():4311-4324. PubMed ID: 32606679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.
    Zhao L; Han F; Wang J; Chen J
    Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury.
    Birtwistle L; Chen XM; Pollock C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34202940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury.
    Zhao L; Hu C; Zhang P; Jiang H; Chen J
    J Cell Mol Med; 2019 Feb; 23(2):720-730. PubMed ID: 30484934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.
    Yun CW; Lee SH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Beneficial Effects of Mesenchymal Stem Cells in Acute Kidney Injury: A Narrative Review.
    Liu Y; Han J; Fang J; Li R
    Curr Stem Cell Res Ther; 2024; 19(2):200-209. PubMed ID: 36748221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of hydrogels for cell-based treatment of chronic kidney disease.
    McFetridge ML; Del Borgo MP; Aguilar MI; Ricardo SD
    Clin Sci (Lond); 2018 Sep; 132(17):1977-1994. PubMed ID: 30220651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells in Kidney Repair.
    Morigi M; Rota C; Remuzzi G
    Methods Mol Biol; 2016; 1416():89-107. PubMed ID: 27236667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges.
    Chen F; Chen N; Xia C; Wang H; Shao L; Zhou C; Wang J
    Cell Transplant; 2023; 32():9636897231164251. PubMed ID: 37013255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.
    Syková E; Jendelová P; Urdzíková L; Lesný P; Hejcl A
    Cell Mol Neurobiol; 2006; 26(7-8):1113-29. PubMed ID: 16633897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.
    Gao J; Liu R; Wu J; Liu Z; Li J; Zhou J; Hao T; Wang Y; Du Z; Duan C; Wang C
    Biomaterials; 2012 May; 33(14):3673-81. PubMed ID: 22361096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ miRNA delivery from a hydrogel promotes osteogenesis of encapsulated mesenchymal stromal cells.
    Carthew J; Donderwinkel I; Shrestha S; Truong VX; Forsythe JS; Frith JE
    Acta Biomater; 2020 Jan; 101():249-261. PubMed ID: 31722255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury.
    Fu Z; Zhang Y; Geng X; Chi K; Liu C; Song C; Cai G; Chen X; Hong Q
    Stem Cell Res Ther; 2023 Apr; 14(1):116. PubMed ID: 37122024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury.
    Li JK; Yang C; Su Y; Luo JC; Luo MH; Huang DL; Tu GW; Luo Z
    Front Immunol; 2021; 12():684496. PubMed ID: 34149726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the route matter? A preclinical review of mesenchymal stromal cell delivery to the kidney.
    Kresse JC; Gregersen E; Atay JCL; Eijken M; Nørregaard R
    APMIS; 2023 Dec; 131(12):687-697. PubMed ID: 37750005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradable hydrogels for spatiotemporal control of mesenchymal stem cells localized at decellularized bone allografts.
    Hoffman MD; Van Hove AH; Benoit DS
    Acta Biomater; 2014 Aug; 10(8):3431-41. PubMed ID: 24751534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.